Results · Apr-Jun 2026
Procter & Gamble Health Q1 FY27 results
Sales grew 7% to ₹364 crore from ₹339 crore in Apr-Jun 2025.
Operating profit grew 10% to ₹99.6 crore, an operating margin of 27.4% (up 0.7 points from a year ago).
Net profit grew 45% to ₹96.2 crore from ₹66.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −2%, net profit +2%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 363.7 | 338.7 | +7% |
| Operating profit (EBITDA) | 99.6 | 90.3 | +10% |
| Operating margin | 27.4% | 26.7% | +0.7 pts |
| Net profit | 96.2 | 66.2 | +45% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.